Saltar ao contenido
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Avanzado
  • Median time to pain improvemen...
  • Citar
  • Text this
  • Enviar este rexistro por email
  • Imprimir
  • Exportar rexistro
    • Exportar a RefWorks
    • Exportar a EndNoteWeb
    • Exportar a EndNote
  • Permanent link
Median time to pain improvement in patients with psoriatic arthritis treated with tofacitinib

Median time to pain improvement in patients with psoriatic arthritis treated with tofacitinib

Detalles Bibliográficos
Main Authors: de Vlam, K, Ogdie, A, Bushmakin, A, Cappelleri, J, Fleischmann, R, Taylor, P, Azevedo, V, Fallon, L, Maniccia, A, Woolcott, J, Mease, P
Formato: Conference item
Publicado: Wiley 2018
  • Existencias
  • Descripción
  • Títulos similares
  • Staff View

Títulos similares

  • Median time to pain improvement and the impact of baseline pain severity on pain response in patients with psoriatic arthritis treated with tofacitinib
    por: de Vlam, K, et al.
    Publicado: (2021)
  • Baseline pain severity as a predictor of pain improvement following treatment with tofacitinib in psoriatic arthritis
    por: Ogdie, A, et al.
    Publicado: (2018)
  • Understanding mediators of pain reduction in psoriatic arthritis patients treated with tofacitinib: role of inflammation
    por: Taylor, P, et al.
    Publicado: (2019)
  • Identifying and quantifying the role of inflammation in pain reduction for patients with psoriatic arthritis treated with tofacitinib: a mediation analysis
    por: de Vlam, K, et al.
    Publicado: (2022)
  • Identifying mediators of pain reduction in patients with psoriatic arthritis treated with tofacitinib: Role of inflammation associated with peripheral arthritis, enthesitis and skin disease
    por: Taylor, PC, et al.
    Publicado: (2020)

Opciones de procura

  • Historial de Procuras
  • Procura avanzada

Buscar Máis

  • Revisar o catálogo
  • Lista alfabética
  • Explore Channels
  • Reservas de curso
  • Novos exemplares

Necesita Axuda?

  • Consello de procura
  • Consulte a un Bibliotecario
  • Preguntas Frecuentes